Latest News & Features
Americas
Pfizer has announced that it will be buying Anacor Pharmaceuticals for $5.2 billion, which will lead to it adding an experimental treatment for eczema, called Crisaborole, to its portfolio. 18 May 2016
Americas
The US Patent and Trademark Office’s Patent Trial and Appeal Board will review one of AbbVie’s patents covering its arthritis treatment drug Humira (adalimumab), following a challenge by drug maker Coherus Bioscience. 18 May 2016
Americas
Jazz Pharmaceuticals has dropped its claims against Ranbaxy, Sun Pharmaceutical and Ohm in a patent infringement case involving narcolepsy drug Xyrem. 18 May 2016
Americas
The US Court of Appeals for the Federal Circuit ruled that Glenmark Pharmaceuticals infringed a Bayer Healthcare patent for the rosacea treatment Finacea. 18 May 2016
Americas
Thermo Fisher Scientific has agreed a $35 million settlement with Enzo Biochem in a patent infringement fight in a Delaware federal court over a pair of DNA testing patents. 17 May 2016
Africa
Biotech was the only technology area out of 12 studied that has shown a global decline in its year-on-year innovation, declining by 2%, according to the “2016 State of Innovation Report: Disruptive, Game-Changing Innovation” by Thomson Reuters. 16 May 2016
Big Pharma
The UK government’s Medicines and Healthcare Products Regulatory Agency has conducted an operation into counterfeit and unlicensed erectile dysfunction medicines across London. 16 May 2016
Americas
The US Court of Appeals for the Federal Circuit has refused to review an earlier ruling that invalidated a patent owned by Howmedica Osteonics in the company’s dispute with medical device company Zimmer. 13 May 2016
Americas
US-based Heritage Pharmaceuticals has warned customers that a counterfeit of a brain cancer treatment drug it owns is being sold abroad. 12 May 2016
Big Pharma
There is a lack of judicial guidance in Europe on the issue of third party supplementary protection certificates (SPCs), otherwise known as “SPC squatting”, as Trevor Cook of WilmerHale explains. 12 May 2016